8th May 2018 12:52
LONDON (Alliance News) - Arix Bioscience PLC on Tuesday noted the planned Nasdaq listing by its largest investee Autolus Therapeutics Ltd.
Autolus - in which Arix held an 8.6% stake as of the end of 2017 - is to place American depositary shares on the Nasdaq, but gave no details as to how many or what price.
Arix's noting of the initial public offering follows a similar one by FTSE 250-listed Syncona Ltd earlier Tuesday.
Shares were up 6.1% on Tuesday at a price of 211.10 pence each.
Related Shares:
ARIX.L